The market saw a partial reversal of speculative unwinding witnessed on Monday. Bulls again took charge in afternoon deals as the ongoing battle between the coronavirus and vaccine tilted in favour of the latter with approval of the third vaccine, with hopes of many more to come.
The 30-share pack Sensex advanced 660.68 points or 1.38 per cent to close at 48,544.06. The index traded in a 852-point range during the day. Its broader peer NSE Nifty rose 194 points or 1.36 per cent to settle at 14,504.80.
“India’s retail inflation for March also rose to 5.52 per cent, however, it did not harm the market sentiment as it was in line with the recent RBI policy forecast. How the lockdowns will affect the economy will determine the trend of the domestic market in the short-term,” said Vinod Nair, Head of Research at Geojit Financial Services.
Market at a glance
- TaMo jumps 5% after co says JLR will report significant free cash flow in Q4
- Fear gauge India VIX tumbles 11% as nervousness wanes
- TCS drops 4% after Q4 earnings; lack of surprises dents morale
- Pharma stocks see profit booking led by Dr Reddy’s Labs
- Adani Ports falls 2% after S&P removes it from sustainability index
